Every SEC Form 3/4/5 on record for this filer (CIK 1516354) — 8 issuers, 9 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | Chief Financial Officer | 2026-02-05 → 2026-06-26 | 3 | −$135,675 |
| MNMD | Mind Medicine (MindMed) Inc. | Chief Financial Officer | 2025-06-02 → 2025-06-02 | 2 | — |
| LBPH | Longboard Pharmaceuticals, Inc. | Executive VP and CFO | 2021-03-11 → 2024-12-02 | 6 | — |
| TFFP | TFF Pharmaceuticals, Inc. | Director | 2022-04-04 → 2024-07-08 | 6 | $5,000 |
| LCTX | Lineage Cell Therapeutics, Inc. | CFO & SVP Finance · lapsed | 2019-08-15 → 2020-03-19 | 2 | $5,050 |
| BTX | BIOTIME INC | CFO & SVP, Finance · lapsed | 2019-01-09 → 2019-07-02 | 3 | — |
| RVA.AX | REVA Medical, Inc. | SVP & Chief Financial Officer · lapsed | 2018-01-23 → 2018-07-02 | 2 | $7,509 |
| MSTX | Mast Therapeutics, Inc. | Chief Financial Officer & SVP · lapsed | 2016-01-06 → 2017-01-23 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| DFTX | 2026-06-25 | Sell | 3,013 | $45.03 | $135,675 | 209,487 |
| TFFP | 2023-08-15 | Buy | 20,000 | $0.25 | $5,000 | 20,000 |
| LCTX | 2019-08-13 | Buy | 5,000 | $1.01 | $5,050 | 5,000 |
| RVA.AX | 2018-06-29 | Buy | 4,908 | $1.53 | $7,509 | 54,908 |
2 of 8 issuers are covered and open a security page; the rest are on file here only.
